Tusamitamab ravtansine | Antibody-Drug Conjugate inhibitor | Read Reviews & Product Use Citations

Tusamitamab Ravtansine (SAR-408701), is an antibody-drug conjugate (ADC) composed of CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule ) targeting antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. TUSAMITAMAB RAVTANSINE has the potential for use in research of several solid tumors.

CAS No. 2254086-60-5

Purity & Quality Control

Batch: D402601 Purity: 99% Protein concentration: 5.75mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Antibody-Drug Conjugate Inhibitors

Biological Activity

Description	Tusamitamab Ravtansine (SAR-408701), is an antibody-drug conjugate (ADC) composed of CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule ) targeting antibody and a cytotoxic maytansinoid tubulin inhibitor DM4. TUSAMITAMAB RAVTANSINE has the potential for use in research of several solid tumors.

References
[1] Ricordel C, et al. Journal of Clinical Oncology 40, no. 16_suppl (June 01, 2022) 9039-9039.

References

[1] Ricordel C, et al. Journal of Clinical Oncology 40, no. 16_suppl (June 01, 2022) 9039-9039.

Product Details

CAS No.	2254086-60-5
ADC antiody	Tusamitamab
ADC cytotoxin	DM4
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field